Adverse Outcome Pathways (AOPs) Archives - ECETOC

Publications

Workshop Report no.38 – Exploring best practices in quantitative AOPs (qAOPs)

Workshop Report no.38 – Exploring best practices in quantitative AOPs (qAOPs)

378213

2024-02-08 15:53:50 read more

Heterogeneity in biological assemblages and exposure in chemical risk assessment: Exploring capabilities and challenges in methodology with two landscape-scale case studies

Heterogeneity in biological assemblages and exposure in chemical risk assessment: Exploring capabilities and challenges in methodology with two landscape-scale case studies

378168

2022-10-18 13:15:06 read more

TR 138 – ECETOC Guidance on Dose Selection

TR 138 – ECETOC Guidance on Dose Selection

378116

2021-03-10 06:37:32 read more

TR 136 – Assessment Factors to Derive DNELs – Critical Evaluation of the Status Quo

TR 136 – Assessment Factors to Derive DNELs – Critical Evaluation of the Status Quo

378112

2021-02-23 10:55:40 read more

Workshop Report no.37 – Online workshop on the scientific feasibility of exposure-based adaptations in the regulatory setting

Workshop Report no.37 – Online workshop on the scientific feasibility of exposure-based adaptations in the regulatory setting

378107

2021-02-16 14:27:01 read more

Workshop Report no.36 – Microbiome Expert Workshop (Porto, 8-9 July 2019)

Workshop Report no.36 – Microbiome Expert Workshop (Porto, 8-9 July 2019)

378096

2020-04-30 07:37:06 read more

Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation

378056

2017-03-02 10:14:22 read more

Technical Report no.128: Guidance on assessment and application of Adverse Outcome Pathways (AOPs) relevant to the Endocrine System

Technical Report no.128: Guidance on assessment and application of Adverse Outcome Pathways (AOPs) relevant to the Endocrine System

378031

2016-12-06 11:54:35 read more

Workshop Report no.32: Noncoding RNAs and Risk Assessment Science. 3 – 4 March 2016, Málaga

Workshop Report no.32: Noncoding RNAs and Risk Assessment Science. 3 – 4 March 2016, Málaga

378018

2016-08-29 05:10:09 read more

View all related publications

Task Forces

Population relevance for NTOs per EU Endocrine Disruption Criteria – Expert Group

Population relevance for NTOs per EU Endocrine Disruption Criteria – Expert Group

387822

2024-01-17 10:53:07 387822

Staged assessment: Exemplify the staged assessment process by using it to provide more information in low tonnage bands

Staged assessment: Exemplify the staged assessment process by using it to provide more information in low tonnage bands

387802

2023-02-17 13:21:27 387802

Smart studies: Examine how in vivo studies could provide more information encompassing novel studies (and endpoints)

Smart studies: Examine how in vivo studies could provide more information encompassing novel studies (and endpoints)

387801

2023-02-17 13:12:35 387801

Use of clinical data in identification of respiratory sensitisers

Use of clinical data in identification of respiratory sensitisers

387799

2022-04-04 08:18:48 387799

Dose Selection Task Force

Dose Selection Task Force

387793

2019-06-13 13:42:29 387793

View all completed task forces